Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-Mediated Repair

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|8|1409-1417

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.8, 2012-06, pp. : 1409-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and Future Therapies Targeting the Immune System in Multiple Sclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 3, 2014-03 ,pp. : 276-296

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 24, Iss. 28, 2017-09 ,pp. : 3054-3067

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Therapy of Multiple Sclerosis - Future Strategies

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4489-4497

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance

By Lu Ellen   Wang Bing Wei   Guimond Colleen   Synnes Anne   Sadovnick A Dessa   Dahlgren Leanne   Traboulsee Anthony   Tremlett Helen  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Current Status and Future Prospective of Immunointervention in Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 13, Iss. 19, 2006-08 ,pp. : 2329-2343

Bentham Science Publishers

Access to resources Recommend Favorite